Variant report

Variant	esv3460455
Chromosome Location	chr2:46910422-46928955
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1007)
CpG islands
(count:795)
Chromatin interactive
region (count:28)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1007 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:46928523-46928754	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:46927741-46927927	K562	blood:	n/a	n/a
3	ARID3A	chr2:46926821-46926840	HepG2	liver:	n/a	n/a
4	ARID3A	chr2:46918093-46918332	HepG2	liver:	n/a	n/a
5	ARID3A	chr2:46925574-46925960	K562	blood:	n/a	n/a
6	ARID3A	chr2:46924704-46926145	HepG2	liver:	n/a	n/a
7	ATF2	chr2:46925530-46926151	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF2	chr2:46925588-46926084	GM12878	blood:	n/a	n/a
9	ATF2	chr2:46925586-46926235	GM12878	blood:	n/a	n/a
10	ATF3	chr2:46925752-46926184	H1-hESC	embryonic stem cell:	n/a	n/a
11	ATF3	chr2:46925672-46926127	GM12878	blood:	n/a	n/a
12	ATF3	chr2:46925735-46926125	GM12878	blood:	n/a	n/a
13	ATF3	chr2:46925762-46926139	HepG2	liver:	n/a	n/a
14	ATF3	chr2:46925510-46926228	HepG2	liver:	n/a	chr2:46925661-46925670
15	ATF3	chr2:46925628-46926257	H1-hESC	embryonic stem cell:	n/a	chr2:46925661-46925670
16	ATF3	chr2:46925728-46926186	K562	blood:	n/a	n/a
17	ATF3	chr2:46925402-46926246	A549	lung:	n/a	chr2:46925661-46925670
18	BACH1	chr2:46926838-46926987	H1-hESC	embryonic stem cell:	n/a	n/a
19	BACH1	chr2:46925618-46926112	H1-hESC	embryonic stem cell:	n/a	n/a
20	BCL3	chr2:46925291-46926156	A549	lung:	n/a	chr2:46925639-46925648 chr2:46925506-46925519 chr2:46925838-46925847
21	BCL3	chr2:46925504-46926171	A549	lung:	n/a	chr2:46925639-46925648 chr2:46925506-46925519 chr2:46925838-46925847
22	BHLHE40	chr2:46925461-46926263	HepG2	liver:	n/a	n/a
23	BHLHE40	chr2:46926499-46926956	HepG2	liver:	n/a	n/a
24	BHLHE40	chr2:46928318-46928710	K562	blood:	n/a	n/a
25	BHLHE40	chr2:46925572-46926280	K562	blood:	n/a	n/a
26	BHLHE40	chr2:46925540-46926328	GM12878	blood:	n/a	n/a
27	BHLHE40	chr2:46926823-46926932	K562	blood:	n/a	n/a
28	BRCA1	chr2:46918079-46918323	Hela-S3	cervix:	n/a	n/a
29	BRCA1	chr2:46925096-46925174	GM12878	blood:	n/a	n/a
30	BRCA1	chr2:46925703-46925892	H1-hESC	embryonic stem cell:	n/a	n/a
31	BRCA1	chr2:46926633-46926802	HepG2	liver:	n/a	n/a
32	BRCA1	chr2:46925603-46925913	HepG2	liver:	n/a	n/a
33	BRCA1	chr2:46925405-46926193	Hela-S3	cervix:	n/a	n/a
34	BRCA1	chr2:46926847-46926889	Hela-S3	cervix:	n/a	n/a
35	CBX3	chr2:46922315-46922888	HCT-116	colon:	n/a	n/a
36	CBX3	chr2:46917914-46918558	HCT-116	colon:	n/a	n/a
37	CBX3	chr2:46925657-46925933	K562	blood:	n/a	n/a
38	CBX3	chr2:46917902-46918429	HCT-116	colon:	n/a	n/a
39	CBX3	chr2:46925392-46926259	K562	blood:	n/a	n/a
40	CCNT2	chr2:46925786-46926881	K562	blood:	n/a	n/a
41	CEBPB	chr2:46919180-46919473	H1-hESC	embryonic stem cell:	n/a	n/a
42	CEBPB	chr2:46927615-46927932	HepG2	liver:	n/a	chr2:46927769-46927780
43	CEBPB	chr2:46925458-46925481	K562	blood:	n/a	n/a
44	CEBPB	chr2:46927596-46927927	K562	blood:	n/a	chr2:46927769-46927780
45	CEBPB	chr2:46927648-46927863	H1-hESC	embryonic stem cell:	n/a	chr2:46927769-46927780
46	CEBPB	chr2:46918008-46918308	Hela-S3	cervix:	n/a	n/a
47	CEBPB	chr2:46927626-46927913	A549	lung:	n/a	chr2:46927769-46927780
48	CEBPB	chr2:46927465-46928062	A549	lung:	n/a	chr2:46927769-46927780
49	CEBPB	chr2:46923393-46923407	HepG2	liver:	n/a	n/a
50	CEBPB	chr2:46925562-46926159	Hela-S3	cervix:	n/a	n/a

(count:795 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:46925381-46925431	ECC-1	luminal epithelium:	n/a
2	chr2:46926217-46926267	AG04450	lung:	fetal
3	chr2:46925381-46925431	ECC-1	luminal epithelium:	n/a
4	chr2:46926217-46926267	AG04450	lung:	fetal
5	chr2:46927010-46927060	HL-60	blood:	n/a
6	chr2:46925753-46925803	HRCEpiC	kidney:	n/a
7	chr2:46925381-46925431	HRPEpiC	eye:	n/a
8	chr2:46926433-46926483	HIPEpiC	eye:	n/a
9	chr2:46926217-46926267	NHDF-neo	bronchial:	n/a
10	chr2:46925129-46925179	AG09309	skin:	n/a
11	chr2:46925970-46926020	HPAEpiC	pulmonary alveolar:	n/a
12	chr2:46926433-46926483	GM19239	blood:	n/a
13	chr2:46926944-46926994	NT2-D1	testis:	n/a
14	chr2:46926944-46926994	HCF	heart:	n/a
15	chr2:46926944-46926994	HAEpiC	amniotic membrane:	n/a
16	chr2:46925333-46925383	Hela-S3	cervix:	n/a
17	chr2:46925129-46925179	HRPEpiC	eye:	n/a
18	chr2:46927010-46927060	HIPEpiC	eye:	n/a
19	chr2:46925129-46925179	SK-N-MC	brain:	n/a
20	chr2:46926944-46926994	HRE	kidney:	n/a
21	chr2:46926272-46926322	HEEpiC	esophagus:	n/a
22	chr2:46926217-46926267	SKMC	muscle:	n/a
23	chr2:46927010-46927060	AoSMC	blood vessel:	n/a
24	chr2:46926190-46926240	SKMC	muscle:	n/a
25	chr2:46926217-46926267	GM12892	blood:	n/a
26	chr2:46926217-46926267	PFSK-1	brain:	n/a
27	chr2:46927010-46927060	BE2_C	brain:	n/a
28	chr2:46926272-46926322	SKMC	muscle:	n/a
29	chr2:46925381-46925431	A549	lung:	n/a
30	chr2:46926842-46926892	NHDF-neo	bronchial:	n/a
31	chr2:46925753-46925803	GM12878	blood:	n/a
32	chr2:46925129-46925179	PrEC	prostate:	n/a
33	chr2:46926069-46926119	HRPEpiC	eye:	n/a
34	chr2:46926190-46926240	AG04450	lung:	fetal
35	chr2:46926433-46926483	BJ	skin:	n/a
36	chr2:46926842-46926892	MCF10A-Er-Src	breast:	n/a
37	chr2:46925129-46925179	Caco-2	colon:	n/a
38	chr2:46927010-46927060	CMK	blood:	n/a
39	chr2:46926272-46926322	Hepatocyte	liver:	n/a
40	chr2:46926190-46926240	HEK293	kidney:	embryo
41	chr2:46926944-46926994	HL-60	blood:	n/a
42	chr2:46926842-46926892	PANC-1	pancreas:	n/a
43	chr2:46925753-46925803	NHDF-neo	bronchial:	n/a
44	chr2:46926217-46926267	Caco-2	colon:	n/a
45	chr2:46925333-46925383	HIPEpiC	eye:	n/a
46	chr2:46926190-46926240	HPAEpiC	pulmonary alveolar:	n/a
47	chr2:46925129-46925179	AG10803	skin:	n/a
48	chr2:46925753-46925803	PFSK-1	brain:	n/a
49	chr2:46926272-46926322	SAEC	small airway:	n/a
50	chr2:46926217-46926267	NB4	blood:	n/a

(count:28 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:46923183..46926073-chr2:46944483..46946206,2	K562	blood:
2	chr15:41047268..41048047-chr2:46926297..46927002,2	Hela-S3	cervix:
3	chr2:46926377..46928977-chr2:47022030..47023631,2	K562	blood:
4	chr2:46918372..46921007-chr2:46925064..46927090,2	MCF-7	breast:
5	chr2:46926502..46928230-chr2:46967700..46969222,2	MCF-7	breast:
6	chr2:46921430..46924294-chr2:46954187..46957185,2	MCF-7	breast:
7	chr2:46916264..46918860-chr2:46922817..46927485,4	K562	blood:
8	chr2:46891705..46893482-chr2:46919094..46921446,2	K562	blood:
9	chr2:46842180..46843861-chr2:46924432..46926384,2	K562	blood:
10	chr2:46916264..46918533-chr2:46923065..46926019,3	K562	blood:
11	chr2:46920025..46923233-chr2:46925972..46929255,3	K562	blood:
12	chr2:46923714..46925684-chr2:46963885..46966277,2	MCF-7	breast:
13	chr2:46916264..46918533-chr2:46923065..46926019,3	K562	blood:
14	chr2:46919532..46921625-chr2:46922624..46924303,3	MCF-7	breast:
15	chr2:46905228..46908369-chr2:46910696..46912754,3	K562	blood:
16	chr2:46915855..46917491-chr2:46923839..46925378,2	MCF-7	breast:
17	chr2:46915855..46917491-chr2:46923839..46925378,2	MCF-7	breast:
18	chr2:46919753..46923455-chr2:46923473..46925760,5	K562	blood:
19	chr2:46921129..46924889-chr2:46924933..46928761,3	MCF-7	breast:
20	chr2:46924915..46928636-chr2:46928946..46932522,6	MCF-7	breast:
21	chr2:46926353..46928054-chr2:46945073..46946618,2	MCF-7	breast:
22	chr2:46897133..46898995-chr2:46922668..46925477,2	K562	blood:
23	chr2:46919753..46923455-chr2:46923473..46925760,5	K562	blood:
24	chr2:46923592..46925257-chr2:47030948..47032802,2	MCF-7	breast:
25	chr2:46919532..46921625-chr2:46922624..46924303,3	MCF-7	breast:
26	chr2:46926271..46927170-chr7:26240072..26240761,2	Hela-S3	cervix:
27	chr2:46917588..46920626-chr2:47107576..47110678,3	K562	blood:
28	chr2:46925509..46928130-chr2:47135510..47137063,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PIGF-4	chr2:46926027-46926053	NONHSAT070524
2	lnc-PIGF-4	chr2:46925253-46925831	NONHSAT070524
3	lnc-SOCS5-3	chr2:46911125-46911684	NONHSAT070522
4	lnc-CRIPT-4	chr2:46926519-46927680	ucscGeneNc_uc002rvj_1
5	lnc-PIGF-2	chr2:46910457-46910666	XLOC_002087

No data

Variant related genes	Relation type
SOCS5	TF binding region
SOCS5	CpG island
ENSG00000137824	chromatin interactions
ENSG00000180398	chromatin interactions
ENSG00000122566	chromatin interactions
ENSG00000119878	chromatin interactions
ENSG00000171150	chromatin interactions

Extended variants
information (count: 724 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:724 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs375456094	chr2:46910448-46910449	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs73926564	chr2:46910488-46910489	Weak transcription Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs112856381	chr2:46910489-46910490	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
4	rs575241442	chr2:46910501-46910502	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
5	rs62136934	chr2:46910509-46910510	Weak transcription Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs370859215	chr2:46910546-46910547	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
7	rs546143066	chr2:46910561-46910562	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
8	rs146543171	chr2:46910617-46910618	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
9	rs528598241	chr2:46910711-46910712	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs540800247	chr2:46910757-46910758	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs562194053	chr2:46910759-46910760	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs529584587	chr2:46910765-46910766	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs564494771	chr2:46910774-46910775	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs72802412	chr2:46910775-46910776	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs530539739	chr2:46910798-46910799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs552266562	chr2:46910800-46910801	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs570542914	chr2:46910861-46910862	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs534733411	chr2:46910901-46910902	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs553128797	chr2:46910909-46910910	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs143252517	chr2:46910935-46910936	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs115826960	chr2:46910938-46910939	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs78759671	chr2:46910941-46910942	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs546907510	chr2:46910950-46910951	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs568203623	chr2:46910951-46910952	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs181538297	chr2:46910969-46910970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs556978050	chr2:46910985-46910986	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs1456011	chr2:46911008-46911009	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs185613845	chr2:46911048-46911049	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs34828013	chr2:46911056-46911057	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs557759397	chr2:46911070-46911071	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs573001019	chr2:46911131-46911132	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
32	rs80150426	chr2:46911154-46911155	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
33	rs538391729	chr2:46911205-46911206	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
34	rs556775520	chr2:46911239-46911240	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
35	rs529470342	chr2:46911254-46911255	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
36	rs544860246	chr2:46911321-46911322	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
37	rs368805383	chr2:46911343-46911344	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
38	rs191342354	chr2:46911410-46911411	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
39	rs563189358	chr2:46911464-46911465	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
40	rs533700500	chr2:46911495-46911496	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
41	rs550537163	chr2:46911508-46911509	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
42	rs113846113	chr2:46911530-46911531	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
43	rs552178764	chr2:46911531-46911532	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
44	rs375470620	chr2:46911536-46911537	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
45	rs570508153	chr2:46911543-46911544	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
46	rs568901449	chr2:46911550-46911551	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
47	rs78139242	chr2:46911598-46911599	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
48	rs141157497	chr2:46911613-46911614	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs78144514	chr2:46911661-46911662	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs142220520	chr2:46911663-46911664	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Non-small cell lung cancer	18927303	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Myelofibrosis	22110671	CNVD
Hypotonia	17579669	CNVD
Hypotonia-Cystinuria syndrome	16385448	CNVD
Glioblastoma multiforme	17002787	CNVD
Cystinuria	17625506	CNVD
Breast cancer	16272173	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Melanoma	20877625	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:708 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:46906000-46911400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr2:46907400-46910800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
3	chr2:46907600-46911200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr2:46907600-46911400	Weak transcription	Osteobl	bone
5	chr2:46907800-46911400	Weak transcription	NHDF-Ad	bronchial
6	chr2:46907800-46911800	Enhancers	Primary B cells from peripheral blood	blood
7	chr2:46908400-46911200	Weak transcription	Muscle Satellite Cultured Cells	--
8	chr2:46908400-46911400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr2:46908400-46912400	Weak transcription	NHLF	lung
10	chr2:46909600-46910800	Enhancers	Primary hematopoietic stem cells short term culture	blood
11	chr2:46909600-46911200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
12	chr2:46909800-46911200	Weak transcription	GM12878-XiMat	blood
13	chr2:46910000-46911600	Enhancers	Primary B cells from cord blood	blood
14	chr2:46910600-46911600	Enhancers	Fetal Muscle Leg	muscle
15	chr2:46910800-46911000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr2:46911000-46911200	Bivalent Enhancer	HepG2	liver
17	chr2:46911000-46911400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
18	chr2:46911000-46911800	Enhancers	HSMMtube	muscle
19	chr2:46911000-46912400	Enhancers	Fetal Kidney	kidney
20	chr2:46911200-46911400	Enhancers	GM12878-XiMat	blood
21	chr2:46911200-46912000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr2:46911200-46912400	Enhancers	Muscle Satellite Cultured Cells	--
23	chr2:46911200-46912600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
24	chr2:46911200-46912600	Enhancers	Hela-S3	cervix
25	chr2:46911400-46911600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr2:46911400-46911600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr2:46911400-46912200	Enhancers	Osteobl	bone
28	chr2:46911400-46912400	Enhancers	A549	lung
29	chr2:46911400-46912800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr2:46911400-46912800	Enhancers	NHDF-Ad	bronchial
31	chr2:46911600-46912400	Enhancers	HUVEC	blood vessel
32	chr2:46911600-46916800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
33	chr2:46911600-46924600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr2:46912000-46917000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
35	chr2:46912200-46917000	Weak transcription	Osteobl	bone
36	chr2:46912400-46912800	Enhancers	NHLF	lung
37	chr2:46912400-46917200	Weak transcription	Muscle Satellite Cultured Cells	--
38	chr2:46912400-46917200	Weak transcription	A549	lung
39	chr2:46912400-46917600	Weak transcription	HUVEC	blood vessel
40	chr2:46912600-46917000	Weak transcription	Hela-S3	cervix
41	chr2:46912800-46916800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr2:46912800-46917000	Weak transcription	NHDF-Ad	bronchial
43	chr2:46912800-46917000	Weak transcription	NHLF	lung
44	chr2:46913000-46913400	Enhancers	Fetal Brain Female	brain
45	chr2:46915800-46916000	Enhancers	Placenta Amnion	Placenta Amnion
46	chr2:46916000-46917200	Weak transcription	Placenta Amnion	Placenta Amnion
47	chr2:46916800-46917000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr2:46916800-46920400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr2:46917000-46917200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr2:46917000-46917600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links